119 related articles for article (PubMed ID: 38261436)
1. The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma.
Uysal M; Beypinar I; Araz M
J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261436
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CEA expression and EGFR mutation status in non-small cell lung cancers.
Yang ZM; Ding XP; Pen L; Mei L; Liu T
Asian Pac J Cancer Prev; 2014; 15(8):3451-5. PubMed ID: 24870738
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen in pleural effusion of patients with lung adenocarcinoma: a predictive marker for EGFR mutation.
Lv YL; Liu HB; Yuan DM; Zhou L; Jin SX; Song Y
Transl Cancer Res; 2019 Aug; 8(4):1027-1034. PubMed ID: 35116846
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum carcinoembryonic antigen level and epidermal growth factor receptor mutations with the influence on the prognosis of non-small-cell lung cancer patients.
Cai Z
Onco Targets Ther; 2016; 9():3873-8. PubMed ID: 27390527
[TBL] [Abstract][Full Text] [Related]
5. Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.
Jin B; Dong Y; Wang HM; Huang JS; Han BH
Acta Pharmacol Sin; 2014 Mar; 35(3):373-80. PubMed ID: 24487967
[TBL] [Abstract][Full Text] [Related]
6. Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM; Lai CH; Chang HC; Chao TY; Tseng CC; Fang WF; Wang CC; Chung YH; Huang KT; Chen HC; Chang YC; Lin MC
Medicine (Baltimore); 2015 Dec; 94(50):e2239. PubMed ID: 26683939
[TBL] [Abstract][Full Text] [Related]
7. Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations.
Yanwei Z; Bo J; Yuqing L; Rong L; Xueyan Z; Song H; Baohui H
J Cancer Res Ther; 2016; 12(1):254-8. PubMed ID: 27072247
[TBL] [Abstract][Full Text] [Related]
8.
Gao XC; Wei CH; Zhang RG; Cai Q; He Y; Tong F; Dong JH; Wu G; Dong XR
Oncol Lett; 2020 Oct; 20(4):61. PubMed ID: 32863894
[TBL] [Abstract][Full Text] [Related]
9. Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.
Ko KH; Hsu HH; Huang TW; Gao HW; Shen DH; Chang WC; Hsu YC; Chang TH; Chu CM; Ho CL; Chang H
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1889-97. PubMed ID: 24852187
[TBL] [Abstract][Full Text] [Related]
10. Value of combining serum carcinoembryonic antigen and PET/CT in predicting
Gu J; Xu S; Huang L; Li S; Wu J; Xu J; Feng J; Liu B; Zhou Y
J Thorac Dis; 2018 Feb; 10(2):723-731. PubMed ID: 29607142
[TBL] [Abstract][Full Text] [Related]
11. [Value of carcinoembryonic antigen levels in predicting the efficacy of EGFR-TKI in advanced non-small cell lung cancer harboring EGFR mutations].
Jin B; Zhang Y; Zhang X; Li R; Lou Y; Niu Y; Huang A; Han B
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(30):2327-31. PubMed ID: 25399971
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma.
Zhang Y; Jin B; Shao M; Dong Y; Lou Y; Huang A; Han B
Tumour Biol; 2014 May; 35(5):4921-8. PubMed ID: 24459065
[TBL] [Abstract][Full Text] [Related]
13. Correlation between pre-treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
Liu J; Zhao YQ; Han X; Hu XF; Wu HB; Chen LJ; Song YP
Intern Med J; 2019 May; 49(5):634-643. PubMed ID: 30379408
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Jiang R; Wang X; Li K
Oncotarget; 2016 May; 7(18):26823-36. PubMed ID: 27072585
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.
Jung M; Kim SH; Hong S; Kang YA; Kim SK; Chang J; Rha SY; Kim JH; Kim DJ; Cho BC
Yonsei Med J; 2012 Sep; 53(5):931-9. PubMed ID: 22869475
[TBL] [Abstract][Full Text] [Related]
16. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
Shoji F; Yoshino I; Yano T; Kometani T; Ohba T; Kouso H; Takenaka T; Miura N; Okazaki H; Maehara Y
Cancer; 2007 Dec; 110(12):2793-8. PubMed ID: 17941001
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations.
Gao Y; Song P; Li H; Jia H; Zhang B
BMC Cancer; 2017 Jul; 17(1):484. PubMed ID: 28705152
[TBL] [Abstract][Full Text] [Related]
18. CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients.
Facchinetti F; Aldigeri R; Aloe R; Bortesi B; Ardizzoni A; Tiseo M
Tumour Biol; 2015 Aug; 36(8):5943-51. PubMed ID: 25731731
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.
Wang Z; Yang S; Lu H
Onco Targets Ther; 2017; 10():3345-3351. PubMed ID: 28744138
[TBL] [Abstract][Full Text] [Related]
20. Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.
Pan YQ; Shi WW; Xu DP; Xu HH; Zhou MY; Yan WH
Chin Med Sci J; 2014 Sep; 29(3):156-61. PubMed ID: 25264883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
